Tocilizumab for the treatment of COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tocilizumab for the treatment of COVID-19

Published:2023-06-19 Issue:8 Volume:21 Page:791-797
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Flisiak Robert¹^ORCID,Flisiak-Jackiewicz Marta²^ORCID,Rzymski Piotr³⁴,Zarębska-Michaluk Dorota⁵^ORCID

Affiliation:

1. Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland

2. Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Bialystok, Bialystok, Poland

3. Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland

4. Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), Poznań, Poland

5. Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2023.2226867

Reference61 articles.

1. COVID-19 cytokine storm: the interplay between inflammation and coagulation

2. Cytokine Storm

3. Dexamethasone in Hospitalized Patients with Covid-19

4. IL-6–based mortality risk model for hospitalized patients with COVID-19

5. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-Targeted Therapies for Depression;The Journal of Clinical Psychiatry;2024-06-24

2. Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review;Vaccines;2023-09-19

3. Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis;Expert Review of Anti-infective Therapy;2023-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3